A detailed history of Teamwork Financial Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Teamwork Financial Advisors, LLC holds 21,252 shares of VRTX stock, worth $9.96 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
21,252
Previous 2,079 922.22%
Holding current value
$9.96 Million
Previous $845,000 951.24%
% of portfolio
1.37%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$407.69 - $446.08 $7.82 Million - $8.55 Million
19,173 Added 922.22%
21,252 $8.88 Million
Q4 2023

Jan 19, 2024

SELL
$343.0 - $410.68 $4.95 Million - $5.93 Million
-14,429 Reduced 87.41%
2,079 $845,000
Q3 2023

Oct 31, 2023

BUY
$338.18 - $362.46 $488,670 - $523,754
1,445 Added 9.59%
16,508 $5.74 Million
Q2 2023

Jul 17, 2023

BUY
$314.42 - $351.91 $4.74 Million - $5.3 Million
15,063 New
15,063 $5.3 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Teamwork Financial Advisors, LLC Portfolio

Follow Teamwork Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teamwork Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teamwork Financial Advisors, LLC with notifications on news.